On July 3rd I posted an entry about a study using Hythiam’s PROMETA protocol for methamphetamine addiction. I told you about their sketchy sales tactics and to expect to hear more about them. Well, this morning’s Join Together email included the announcement below stating that they withdrew their summary of the study from their site.
The June 30 research summary Anti-Anxiety Drug Said to Help Meth Addicts, which appeared in the July 3 edition of JT Direct, has been withdrawn from our service. It reports preliminary uncontrolled results from off label use of a medication approved for a condition that is not addiction. The FDA has not approved this treatment modality, nor has it been supported by peer reviewed NIH research.